Overview
Source BioScience provides laboratory services in genomics, multi-omics, histopathology, digital pathology, molecular diagnostics, and proteomics for pharmaceutical R&D and clinical applications. The company supports drug discovery, development research, clinical trials, and precision medicine with advanced sequencing, biomarker validation, and AI-assisted analysis. It offers accredited facilities compliant with ICH guidelines, GLP, and Human Tissue Authority licensing, enabling end-to-end solutions from research to diagnostics.
Frequently asked questions
- What laboratory services does Source BioScience offer for pharma R&D?
- Services include genomics (Sanger and next-generation sequencing), multi-omics (genomics, proteomics, metabolomics, transcriptomics), histopathology, digital pathology with AI, molecular diagnostics, and biomarker validation to support drug discovery, clinical trials, and precision medicine.
- What regulatory accreditations and compliances does Source BioScience hold?
- The company holds accreditations in clinical pathology, GLP, GCP, GMP, and is licensed by the Human Tissue Authority. Facilities comply with ICH Q1B guidelines for stability testing and photostability.
- In which geographies does Source BioScience operate?
- Source BioScience is a European leader with operations focused in Europe, providing services to biotechnology, pharmaceutical, healthcare, and academic sectors across the region.